Published in Health Insurance Week, March 27th, 2005
"The cell surface antigen, CD38, is a 45-kDa transmembrane protein which is predominantly expressed on hematopoietic cells during differentiation," researchers in Canada explained. "As a bifunctional ectoenzyme, it catalyzes the synthesis of cyclic ADP-ribose (cADPR) from NAD+ and hydrolysis of either NAD+ or cADPR to ADP-ribose."
"All-trans-retinoic acid (RA) is a potent and specific inducer of CD38 in myeloid cells," noted L. Yalcintepe and colleagues at the British Columbia Cancer Agency. In a recent study, they found...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.